Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-18,812
Closed -$45K 3250
2025
Q3
$45K Buy
+18,812
New +$51.3K ﹤0.01% 2613
2025
Q2
Sell
-23,387
Closed -$62K 2710
2025
Q1
$62K Buy
+23,387
New +$90.7K ﹤0.01% 2215
2023
Q2
Sell
-257,945
Closed -$1.07M 2543
2023
Q1
$1.07M Buy
257,945
+201,373
+356% +$1.06M 0.01% 916
2022
Q4
$263K Buy
56,572
+43,403
+330% +$238K ﹤0.01% 1798
2022
Q3
$79K Buy
+13,169
New +$106K ﹤0.01% 2412
2021
Q3
Sell
-110,203
Closed -$2.5M 3321
2021
Q2
$2.5M Buy
110,203
+90,552
+461% +$1.96M 0.02% 527
2021
Q1
$449K Sell
19,651
-12,590
-39% -$295K ﹤0.01% 1868
2020
Q4
$703K Buy
+32,241
New +$531K 0.01% 840

Other funds holding CDXS

HRT Financial's CDXS Position: Q4 2025 in Review

HRT Financial sold out of Codexis (CDXS) in Q4 2025, closing a stake of 18,812 shares — an estimated $45K sold.

HRT Financial first reported a position in CDXS in Q4 2020 and held it in 8 quarters. The position peaked at $2.5M in Q2 2021. 124 funds tracked by Wall St. Rank hold CDXS as of Q4 2025.

  • HRT Financial reported no remaining Codexis position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 18,812 Codexis shares in Q4 2025, an estimated $45K.
  • HRT Financial first reported a position in Codexis in Q4 2020 and held it in 8 quarters.
  • HRT Financial's Codexis position peaked at $2.5M in Q2 2021.
  • 124 funds tracked by Wall St. Rank held Codexis as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.